Ravi Ambani, MD, and Aravinda Nanjundappa, MBBS, MD, discuss Cleveland Clinic’s leadership and progress in treating carotid artery disease. Learn how multidisciplinary teams are transforming care with new research on medical and surgical therapies.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension caused by chronic blood clots in the lungs. It is an under-recognized condition, but with accurate imaging and quality treatment, it can often be cured. Gustavo Heresi, MD, and Michael Tong, MD, discuss diagnosis, medical therapy and surgical options for people with CTEPH.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

When treating mitral valve disease, a surgeon must decide whether to repair or replace a valve. Cleveland Clinic experts discuss robotically-assisted surgery, reoperations and the outcomes a patient can expect from surgery at Cleveland Clinic.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Meet the presenters:
Marc Gillinov, MD, Heart Surgeon, Chair of Thoracic and Cardiovascular Surgery https://my.clevelandclinic.org/staff/2350-a-marc-gillinov

Per Wierup, MD, PhD, Heart Surgeon, Department of Cardiovascular Surgery https://my.clevelandclinic.org/staff/22492-per-wierup

Connective tissue disorders like Marfan, Loeys-Dietz, and Ehlers-Danlos syndromes can affect the function of the heart and aorta. Cleveland Clinic experts discuss surgical options, recovery and expected outcomes for those with connective tissue disorders.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Meet the Presenters:
Lars Svensson, MD, PhD
Chief of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute
https://my.clevelandclinic.org/staff/4359-lars-svensson

Milind Desai, MD, MBA
Vice-Chair of Education, Heart, Vascular and Thoracic Institute
https://my.clevelandclinic.org/staff/6670-milind-desai

Learn more about the Cardiovascular Marfan & Connective Tissue Clinic. https://my.clevelandclinic.org/departments/heart/depts/cardiovascular-marfan-connective-tissue

Connective tissue disorders like Marfan, Loeys-Dietz, and Ehlers-Danlos syndromes can affect the function of the heart and aorta. Cleveland Clinic experts discuss the diagnosis of these genetic conditions and indications for heart and aorta treatment in patients with connective tissue disorders in part one of this two-part series.

Meet the Presenters:
Lars Svensson, MD, PhD
Chief of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute
https://providers.clevelandclinic.org/provider/lars-svensson/4268150

Milind Desai, MD, MBA
Vice-Chair of Education, Heart, Vascular and Thoracic Institute
https://providers.clevelandclinic.org/provider/milind-desai/4268324

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Learn more about the Cardiovascular Marfan & Connective Tissue Clinic. https://my.clevelandclinic.org/departments/heart/depts/cardiovascular-marfan-connective-tissue

G. Jay Bishop, MD, and Aravinda Nanjundappa, MBBS, MD, explore Cleveland Clinic’s latest advances in vascular medicine, from research on aortic aneurysm biomarkers to innovative treatments for pulmonary embolism, hypertension, and peripheral artery disease. Learn how multidisciplinary teams are transforming care with new research on cutting-edge therapies.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Learn about the promising results of a fixed-dose combination therapy trial that achieved up to a 50% reduction in LDL cholesterol. Steven Nissen, MD and Ashish Sarraju, MD discuss how this CETP inhibitor-based therapy compares to monotherapies, its potential role in treating high-risk cardiovascular patients, and what it could mean for the future of hyperlipidemia management.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Persistent or recurrent atrial fibrillation (AFib) following ablation remains a clinical challenge, especially when it occurs more than three months after an ablation. Expert Cleveland Clinic electrophysiologists discuss the causes for recurrent AFib and review current management strategies, including redo ablation and surgical intervention.
Meet the presenters:
Oussama Wazni, MD, MBA, Section Head of Electrophysiology https://my.clevelandclinic.org/staff/7336-oussama-wazni
Ayman Hussein, MD, Director of Research in Electrophysiology https://my.clevelandclinic.org/staff/21286-ayman-hussein
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.